Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
About this study
This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group. Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years
- Condition
- Invasive Breast Cancer Early Stages
- Sponsor
- Spanish Breast Cancer Research Group
Who can join
- Age
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
Inclusion 5
- Minimum age: 18 years
- Eligible sex: Female
- Study condition: Invasive Breast Cancer Early Stages
- Patients included in neoadjuvant and adjuvant clinical trials with GEICAM's participation. If any of these patients had taken part or is participating in another clinical trial, she/he is eligible for this trial and her/his information will also be collected.
- Patients whose death or contact loss has not been previously collected in the databases of the original studies.
Exclusion 1
- Patient who were not included in the analyses of the original studies due to non-compliance of the eligibility criteria or the original study informed consent withdrawal.
Where
73 sites, 73 recruiting
Centro Oncológico de Galicia
A Coruña, Spain
Complejo Hospitalario A Coruña
A Coruña, Spain
Complejo Hospitalario Universitario de Albacete
Albacete, Spain
Hospital General Universitario de Alicante
Alicante, Spain
Hospital General Universitario de Elche
Alicante, Spain
Hospital General Universitario de Elda
Alicante, Spain
and 67 more sites on ClinicalTrials.gov
Contact
-
Study Project Manager
00346592870 inicio_ensayos@geicam.org
-
Start-Up Unit Manager
00346592870 inicio_ensayos@geicam.org
Potential match only. Final eligibility is determined by the study team.